Viewing Study NCT00075933


Ignite Creation Date: 2025-12-25 @ 3:03 AM
Ignite Modification Date: 2025-12-26 @ 1:43 AM
Study NCT ID: NCT00075933
Status: COMPLETED
Last Update Posted: 2009-04-28
First Post: 2004-01-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: ARQ 501 in Subjects With Cancer
Sponsor: ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module